Rensel M[au] - Search Results

Year	Number of Results
1998	1
2001	1
2007	3
2008	3
2009	3
2010	4
2011	6
2012	2
2013	2
2014	4
2015	3
2016	2
2017	3
2018	9
2019	7
2020	8
2021	9
2022	9
2023	14
2024	1

1

Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4-immunoglobulin G-seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trial.

Rensel M, Zabeti A, Mealy MA, Cimbora D, She D, Drappa J, Katz E. Rensel M, et al. Mult Scler. 2022 May;28(6):925-932. doi: 10.1177/13524585211047223. Epub 2021 Oct 1. Mult Scler. 2022. PMID: 34595983 Free PMC article. Clinical Trial.

2

Reproductive issues and multiple sclerosis: 20 questions.

Carlson AK, Ontaneda D, Rensel MR, Cohen JA, Kunchok A. Carlson AK, et al. Among authors: rensel mr. Cleve Clin J Med. 2023 Apr 3;90(4):235-243. doi: 10.3949/ccjm.90a.22066. Cleve Clin J Med. 2023. PMID: 37011959 Free article. Review.

3

Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis.

Macaron G, Feng J, Moodley M, Rensel M. Macaron G, et al. Among authors: rensel m. Curr Treat Options Neurol. 2019 Sep 27;21(10):50. doi: 10.1007/s11940-019-0592-z. Curr Treat Options Neurol. 2019. PMID: 31560095 Review.

4

Wellness and the Role of Comorbidities in Multiple Sclerosis.

Moss BP, Rensel MR, Hersh CM. Moss BP, et al. Among authors: rensel mr. Neurotherapeutics. 2017 Oct;14(4):999-1017. doi: 10.1007/s13311-017-0563-6. Neurotherapeutics. 2017. PMID: 28785958 Free PMC article. Review.

5

Safety of Newer Disease Modifying Therapies in Multiple Sclerosis.

Jalkh G, Abi Nahed R, Macaron G, Rensel M. Jalkh G, et al. Among authors: rensel m. Vaccines (Basel). 2020 Dec 26;9(1):12. doi: 10.3390/vaccines9010012. Vaccines (Basel). 2020. PMID: 33375365 Free PMC article. Review.

6

Determinants and significance of corticosterone regulation in the songbird brain.

Rensel MA, Schlinger BA. Rensel MA, et al. Gen Comp Endocrinol. 2016 Feb 1;227:136-42. doi: 10.1016/j.ygcen.2015.06.010. Epub 2015 Jun 30. Gen Comp Endocrinol. 2016. PMID: 26141145 Free PMC article. Review.

7

Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms-A Narrative Review.

Lakin L, Davis BE, Binns CC, Currie KM, Rensel MR. Lakin L, et al. Among authors: rensel mr. Neurol Ther. 2021 Jun;10(1):75-98. doi: 10.1007/s40120-021-00239-2. Epub 2021 Apr 20. Neurol Ther. 2021. PMID: 33877583 Free PMC article. Review.

8

Environment, glucocorticoids, and the timing of reproduction.

Schoech SJ, Rensel MA, Bridge ES, Boughton RK, Wilcoxen TE. Schoech SJ, et al. Among authors: rensel ma. Gen Comp Endocrinol. 2009 Sep 1;163(1-2):201-7. doi: 10.1016/j.ygcen.2008.09.009. Epub 2008 Oct 1. Gen Comp Endocrinol. 2009. PMID: 18938168 Review.

9

Long-Term Treatment Strategies of Pediatric Multiple Sclerosis, Including the use of Disease Modifying Therapies.

Rensel M. Rensel M. Children (Basel). 2019 May 31;6(6):73. doi: 10.3390/children6060073. Children (Basel). 2019. PMID: 31159312 Free PMC article. Review.

10

Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review.

Davis BE, Lakin L, Binns CC, Currie KM, Rensel MR. Davis BE, et al. Among authors: rensel mr. Neurol Ther. 2021 Jun;10(1):99-119. doi: 10.1007/s40120-021-00240-9. Epub 2021 Apr 20. Neurol Ther. 2021. PMID: 33877584 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

78 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year